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Menthol belongs to monoterpene class of a structurally diverse group of phytochemicals
found in plant-derived essential oils. Menthol is widely used in pharmaceuticals,
confectionary, oral hygiene products, pesticides, cosmetics, and as a flavoring agent. In
addition, menthol is known to have antioxidant, anti-inflammatory, and analgesic effects.
Recently, there has been renewed awareness in comprehending the biological and
pharmacological effects of menthol. TRP channels have been demonstrated to mediate
the cooling actions of menthol. There has been new evidence demonstrating that menthol
can significantly influence the functional characteristics of a number of different kinds of
ligand and voltage-gated ion channels, indicating that at least some of the biological and
pharmacological effects of menthol can be mediated by alterations in cellular excitability.
In this article, we examine the results of earlier studies on the actions of menthol with
voltage and ligand-gated ion channels.
Keywords: monoterpenes, voltage-gated ion channels, ligand-gated ion channels, TRP channels, menthol
INTRODUCTION
Menthol, a naturally occurring cyclic monoterpene alcohol of plant origin, gives plants of the
Mentha species their distinctive smell and flavor. In Japan for more than 2,000 years, peppermint
plant, the main source of menthol, has been cultivated for medicinal purposes (Patel et al., 2007).
Menthol is also an important constituent of essential oils such as eucalyptus, lemongrass, and
palmarosa. In the present day, menthol is widely used in oral hygiene products, confectionary,
pharmaceuticals, cosmetics, pesticides, and as a flavoring agent. With regards to its medicinal
purposes, both prescribed and over-the-counter menthol containing medications are currently
available for a host of conditions, including respiratory diseases, gastrointestinal disorders,
common cold, and musculoskeletal pain (Eccles, 1994; Patel et al., 2007). In addition, it is
commonly used as part of analgesic, antiseptic, topical antipruritic, and cooling formulations. It
is estimated that ∼30,000 metric tons of menthol are consumed annually (Kamatou et al., 2013).
After citrus and vanilla, menthol is one of the most important flavoring substances in culinary
industry. It is also a commonly used compound in many tobacco products. The estimated use
Abbreviations: ACh, Acetylcholine; AP, Action potential; CAP, Compound action potential; CNS, Central nervous system;
DRG, Dorsal root ganglion; GABA, Gamma-aminobutyric acid; GPCR, G-protein coupled receptor; VGIC, Voltage-gated
ion channel; LGIC, Ligand-gated ion channel; TRP, Transient-receptor potential; TTX, Tetrodotoxin; VGCC, Voltage-gated
calcium channel; VGSC, Voltage-gated sodium channel.
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pattern for L-menthol at the beginning of twenty-first century is
as follows: 36% oral care products, 22% pharmacy products, 19%
tobacco products, 17% flavors, 6% others (OECD, 2003). Despite
menthol’s use since antiquity, the mechanisms mediating its
pharmacological actions remain relatively unknown. The focus
of this report is to highlight the recent advances in the menthol
research and to provide an overview of its actions on cellular
excitability.
Menthol [5-methyl-2-(1-methylethyl) cyclohexanol; 2-
isopropyl-5-methylcyclohexanol or p-methan-3-ol], with
the molecular formula C10H20O (MW. 156.27), is a natural
compoundwith three asymmetric carbon atoms and, thus, occurs
as four pairs of optical isomers namely, (+)- and (−)-menthol,
(+)- and (−)-neomenthol, (+)- and (−)-neoisomenthol, and
(+)- and (−)-isomenthol (Figure 1). The major form of menthol
found in nature is (−)-menthol (L-menthol). (−)-Menthol is
frequently employed since it retains better cooling properties
than the other isomers (Figure 1). Menthol is a colorless or
white, crystalline, and flaky substance. Depending on its purity,
menthol has a melting point of 41–44◦C and it is solid at room
temperature (25◦C) with a density of 0.890 g/cm3. It is not
completely soluble in water (431 mg/L at 20◦C), but freely
soluble in chloroform, diethyl ether, and alcohol (Kamatou et al.,
2013) with Logoctanol/water value of 3.4, indicating that menthol is
a lipophilic compound capable of interacting with membranes
(Turina et al., 2006).
All menthol isomers are absorbed well through oral route of
exposure and are excreted mainly as glucuronides. In rats, an
extensive enterohepatic circulation additionally leads to various
hydroxylated degradation products. Main elimination pathway
for glucuronides and degradation products is via urine; however,
FIGURE 1 | Structure of menthol isomers (from left to right, top row): (+)-Menthol, (−)-Menthol, (+)-Isomenthol, (−)-Isomenthol, (+)-Neomenthol, (−)-Neomenthol,
(+)-Neoisomenthol, (−)-Neoisomenthol.
small quantities are removed via feces. For all isomers of menthol,
a very low acute oral toxicity with LD50 values normally greater
than 2,000 mg/kg bw has been reported. In an earlier report, rats
receiving diets with up to 200 mg/kg bw/d of menthol for 5.5
weeks showed no signs of toxicity (National Toxicology Program,
1979; OECD, 2003).
EFFECTS OF MENTHOL ON ION
CHANNELS
Ion channels are pore-forming integral membrane proteins
that regulate the transfer of charged ions (Ca2+, K+, Na+,
or Cl−) through the bilayer membrane of the cell and
regulate resting membrane potential, action potentials and
other electrical signals. Channel opening is usually triggered
by a specific stimulus such as membrane depolarization,
mechanical stretch, or binding to a ligand. Ionic currents
produced by the passage of ions through these channels
constitutes the electrophysiological origin for several cellular
events including the release of neurotransmitters, muscle
contraction, cell development, secretion of hormones, various
transmembrane signaling processes, and excitation-transcription
coupling (Cannon et al., 2014; Tien et al., 2014). It is known
that several chemicals demonstrate their therapeutic actions by
influencing the functions of ion channels in different types
of cells. In recent years, there has been considerable interest
in pharmacological targets of menthol. Actions of menthol
on various ion channels have been reported in several recent
investigations. The results of some of these recent studies will be
reviewed in the following sections (Table 1).
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TABLE 1 | Summary of cellular and molecular effects of menthol.
Target protein or cellular event End-point
measured
Effect Concentration and ligand Preparation References
Na+ channels Ion current Inhibition IC50 = 376 µM (In neuronal Na
+
channels)
HEK293 cells Haeseler et al., 2002
IC50 = 571 µM (In skeletal
muscle Na+ channels)
Na+ channels Ion current Inhibition IC50 = 297 µM Cultured dorsal horn neurons Pan et al., 2012
TTX-resistant Na+ channels Ion current Inhibition IC50 = 299–500 µM DRG neurons and immortalized
DRG neuron-derived F11 cells
Gaudioso et al., 2012
Nav1.8 channel subtype >300 µM
540–807 µM
Nav1.9 channel subtype
TTX-sensitive Na+ channels
Na+ channels Compound action
potential
Inhibition IC50 = 1.1 mM (−)-menthol Frog sciatic nerve fibers Kawasaki et al., 2013
IC50 = 0.9 mM (+)-Menthol
Na+ channels Number and
duration of action
potential bursts
Inhibition 250 µM Mouse cortical neurons Pezzoli et al., 2014
DHP-sensitive and
DHP-insensitive Ca2+ channels
Ion current Inhibition IC50 = 0.25 mM LA-N-5 cells Sidell et al., 1990
Ca2+ channels High K+-induced
intracellular Ca2+
increase
Inhibition 2 mM Leech neurons Dierkes et al., 1997
Ca2+ channels Ca2+ uptake and
contractile
response
Inhibition IC50 = 8–28 µg/ml Ilium Hawthorn et al., 1988
IC50 = 10–69 µg/ml Cardiac tissue synaptosomes
and chick retinal neurons
Ca2+ channels KCl-preconstricted
smooth muscle
contraction
Inhibition IC50 = 58 µM Bronchial smooth muscle fibers Wright et al., 1997
IC50 = 120 µM
ACh-
preconstricted
smooth muscle
contraction
Ca2+ channels Intracellular Ca2+ Inhibition 0.01–1 mM Tracheal smooth muscle fibers Ito et al., 2008; Wang
et al., 2016
Ca2+ channels Intracellular Ca2+ Inhibition 300 µM Detrusor muscle Ramos-Filho et al.,
2014
Ca2+ channels Intracellular Ca2+ Inhibition 0.1–1 mM Vas deference Filippov et al., 2009;
Vladymyrova et al.,
2011
Ca2+ channels Ca2+ influx and
smooth muscle
relaxation
Inhibition 0.1–1 mM Rat aorta, mesenteric and
coronary arteries
Cheang et al., 2013
Ca2+ channels Ca2+ influx and
contraction
Inhibition 0.1–30 mM Gastrointestinal smooth muscle
and human colon circular muscle
Amato et al., 2014a
Ca2+ channels High K+ and
Ca2+ evoked
contractions
Inhibition IC50 = 22.1 µg/mL Guinea pig taenia coli Hills and Aaronson,
1991
IC50 = 25.9 µg /mL Guinea pig colon
IC50 = 15.2 µg /mL Rabbit jejunum
Ca2+ channel Ca2+ current Inhibition 0.1–0.5 mM Helix neurons Swandulla et al., 1986
Low voltage-activated Ca2+
channel (T-type like) and high
voltage activated Ca2+ channel
(L-type like)
Ca2+ current Inhibition 0.1–1 mM Cultured DRG neurons Swandulla et al., 1987
L-type VGCCs Ca2+ current Inhibition IC50 = 74.6 Rabbit ventricular myocyte Baylie et al., 2010
TRPM8 Ca2+ current Activation 300 µM Rat tail artery myocytes Melanaphy et al., 2016
(Continued)
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TABLE 1 | Continued
Target protein or cellular event End-point
measured
Effect Concentration and ligand Preparation References
L-type VGCCs Inhibition
IP3 receptors Activation
Ryanodine receptors Ca2+ efflux Activation EC50 =1 mM Isolated sarcoplasmic reticulum Palade, 1987; Mahieu
et al., 2007; Neumann
and Copello, 2011
HEK239 cells
Ca2+-activated K+ channels Ion current Activation 100 µM Human glioblastoma cells Wondergem and
Bartley, 2009
Kv7.2/3 channel Ion current Suppression IC50 = 289 µM Cultured sensory neurons Vetter et al., 2013
TRPM8 channels Intracellular Ca2+ Activation 10 µM and 100 µM CHO cells McKemy et al., 2002;
Peier et al., 2002
EC50 = 66.7 µM Xenopus laevis oocytes
TRPM8 channels Menthol sensitivity
of TRPM8 channel
Altered 10, 100, and 1000 µM Mutant voltage sensor residues
(TM4 and TM4-TM5 linker) of
human TRPM8 channel
expressed in HEK 293 cells
Voets et al., 2007
TRPM8 channels Menthol sensitivity
to TRPM8 channel
Reduction 300 µM Mutant tyrosine 745 residue in
TM2 of mouse TRPM8
Bandell et al., 2006
TRPM8 channels Ion current Activation EC50 = 4–80 µM Trigeminal ganglia neuronal cells McKemy et al., 2002;
Peier et al., 2002;
Behrendt et al., 2004
CHO Cells
HEK293 calls
TRPV3 channels Ion current Activation 0.5–2 mM CHO cells Macpherson et al.,
2006; Vogt-Eisele
et al., 2007
1 mM HEK293 cells
Primary keratinocyte culture
TRPA1 channels Ion current Activation (at
low
concentration)
1–30 µM CHO cells Macpherson et al.,
2006; Karashima
et al., 2007; Kim et al.,
2016
1–10 µM Interstitial cells of Cajal
CHO cells
Inhibition (at
high
concentration)
0.25–1 mM
TRP-independent effects Intracellular Ca2+ Inhibition EC50 = 0.9–1 mM Skeletal muscle sarcoplasmic
reticulum
Palade, 1987;
Takeuchi et al., 1994;
Tsuzuki et al., 2004;
Lu et al., 2006;
Mahieu et al., 2007;
Wondergem and
Bartley, 2009;
Neumann and
Copello, 2011
100 µM–1 mM Tracheal epithelial cells
25–100 µM Human leukemia cells
100 µM Gliablastoma cells
100 µM–1 mM Cell lines and dorsal horn
neurons
PCL enzyme activity P2Y
purinoreceptor-
mediated/histamine
receptor-mediated
cytosolic Ca2+
mobilization
Inhibition 0.3–1 mM HEK-293 cells Kim et al., 2008
HeLa cells
(Continued)
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TABLE 1 | Continued
Target protein or cellular event End-point
measured
Effect Concentration and ligand Preparation References
Anion transport CFTR-mediated
Cl− transport
Potentiation 0.1–1 mM Human airway Calu-3 epithelial
cells
Morise et al., 2010
Na+-K+-2Cl−
transporter
Down
regulation
GABAA (α1β2γ2s) receptors Ion current Potentiation EC50 = 25 µM Xenopus laevis oocytes Hall et al., 2004
Glycine (α1 homomers) receptors EC50 = 75 µM
GABAA receptors Righting reflex Inhibition EC50 = 23 µM In vivo tadpole assay Watt et al., 2008
GABAA receptors [
3H]-flunitrazepam
binding
No effect Up to 500 µM Cultured mouse cortical neurons García et al., 2006;
Corvalán et al., 2009
Stimulation EC50 = 1.55 µM Membranes from chick forebrain
GABAA receptors [
3H]-TBOB binding Inhibition LD50= 128.9 µg fly
−1 Housefly head membrane
preparations
Tong and Coats, 2012
GABAA receptors Ion current Activation 100 µM Cultured rat hippocampal
neurons
Zhang et al., 2008
GABAA receptors Ion current Activation 0.1–1 mM brainstem-spinal cord of
newborn rats
Tani et al., 2010
GABAA receptors Ion current Activation 150–750 µM Periaqueductal gray (PAG)
neurons of midbrain slices
Lau et al., 2014
5-HT3 receptors [
14C] guanidinium
influx
Inhibition 10 µM–1 mM N1E-115 cells Heimes et al., 2011
Isotonic
contractions
Inhibition Isolated rat ileum
5-HT3A receptors Ion current inhibition IC50 = 163 µM. Xenopus laevis oocytes Ashoor et al., 2013a
Human recombinant homomeric
5-HT3A
Ca2+ influx Inhibition IC50 = 4.75 mM for (−)-menthol HEK293 cells Walstab et al., 2014
Human recombinant heteromeric
5-HT3AB receptors
IC50 = 4.75 mM for (+)-Menthol
IC50 = 4.46 mM for (−)-menthol
IC50 = 4.60 mM for (+)-Menthol
Nicotinic receptors Nicotine-induced
irritation and
sensory
perception
Reduction 0.3% L-menthol Tongue (human subject) Dessirier et al., 2001
Nicotinic receptors Respiratory
irritation response
Reduction 16 ppm Female C57BL/6J mice Willis et al., 2011
Nicotinic receptors nicotine-induced
hypothermia
Inhibition 100-400 mg/Kg Male adult rats Ruskin et al., 2008
Nicotinic receptors Gastric relaxation Induction 0.3-30 mM Male adult mice Amato et al., 2014b
Nicotinic receptors (α4β2
nAChRs)
Ion current Inhibition IC50 = 111 µM. Trigeminal neurons in HEK
tsA201 cells
Hans et al., 2012
Nicotinic receptors (α4β2
nAChRs)
Density of α4β2
nAChR in menthol
smokers
Up-
regulation
Menthol cigarette smokers vs
nonsmokers
Human subjects Brody et al., 2013
Nicotinic receptors subunits α4 and α6 nAChR
subunits
Up-
regulation
2 mg/kg/h for in vivo upregulation
assays
Midbrain dopaminergic neurons
from mice
Henderson et al.,
2016
(α4)3(β2)2 nAChR
subunits
Up-
regulation
500 nM Neublastoma cells
Decay phase of
current
Acceleration 2 mg/kg/10d Mouse brain slices
Nicotinic receptors (α7 nAChRs) Ion current Inhibition IC50 = 32.6 µM Xenopus laevis oocytes Ashoor et al., 2013b
Nicotinic receptors (α3β4
nAChRs)
Ion current Desensitization Up to 1 mM HEK 293 cells and mouse
sensory neurons
Ton et al., 2015
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Voltage-Gated Sodium Channels
Voltage-gated sodium channels (VGSCs) have essential roles
in the generation and propagation of action potentials (APs)
in excitable cells including neurons, cardiomyocytes, smooth
muscle cells, and skeletal muscle fibers (Savio-Galimberti et al.,
2012; Peters and Ruben, 2014). VGSCs are stimulated by
the changes in membrane potential. The depolarizing changes
are detected by a voltage sensor connected to the pore
domain that opens and allows the influx of sodium. Local
anesthetics, antinociceptive, antiarrhythmic, and antiepileptic
drugs antagonize the functions of ion channels by binding to
a specific site located on the protein structure, whereas other
classes of chemicals and neurotoxins bind to distinct receptor
sites within the pore of the channel (for a review, Catterall et al.,
2013).
Various over-the-counter products for pain relief and topical
balms often contain menthol in the concentrations ranging from
5 to 16% (320–1,024 mM). In this concentration range, topical
application of menthol has been shown to be antinociceptive
for heat and cold-induced pain (Green, 1986; Albin et al.,
2008; Klein et al., 2010, 2012). Menthol has also been shown
to have anti-nociceptive actions in the mouse abdominal
constriction and hot-plate tests (Galeotti et al., 2002). Anti-
nociceptive actions of menthol were stereo-selective, since only
(−) enantiomer was active in in vivo models. Local anesthetic
activity of menthol has also been demonstrated in earlier
studies (Galeotti et al., 2001). However, both (−) and (+)
isomers of menthol are equally active in their local anesthetic
actions.
The effect of menthol on sodium channels was tested
in an earlier patch-clamp study (Haeseler et al., 2002) in
HEK293 cells transfected with human skeletal muscle and
rat neuronal VGSCs. Menthol suppressed whole cell Na+
currents with an IC50 value of 571 and 376 µM for neuronal
cells and skeletal muscle fibers, respectively. The strength of
menthol effects enhanced significantly at depolarized potentials
with increasing portion of inactivated channels, suggesting
that preferential blockade of VGSC in inactivated state may
mediate antinociceptive and local anesthetic effects of menthol
(Haeseler et al., 2002). In another electrophysiological study,
Gaudioso et al. (2012), using whole-cell patch clamp method,
investigated the actions of menthol on tetrodotoxin (TTX)-
sensitive VGSCs in immortalized dorsal root ganglia (DRG)
neuron-derived F11 cells and on TTX-resistant Nav1.9 and
Nav1.8 channel subtypes in DRG neurons, and (Gaudioso et al.,
2012). It was found that VGSCs were suppressed by menthol
in a concentration, frequency, and voltage-dependent manner.
Firing at high-frequency stimulation was suppressed by menthol
while minimal effect was observed on normal neuronal activity
recorded by current clamp technique. In addition, menthol at
low concentrations caused analgesia and relieved pain produced
by a Na+ channel-targeting toxin in mice. In conclusion, the
results of this study indicated that Nav1.8, Nav1.9, and TTX-
sensitive Na+ channels are blocked bymenthol in a state-selective
manner suggesting a role for Na+ channel blockade in the efficacy
of menthol as topical analgesic compound (Gaudioso et al.,
2012).
Menthol, by dose-dependently diminishing both contralateral
and ipsilateral pain hypersensitivity produced by complete
Freund’s adjuvant, showed direct effects on the spinal cord
(Pan et al., 2012). In addition, both first and second stages
of formalin-induced spontaneous nocifensive behavior were
attenuated bymenthol. In cultured dorsal horn neurons, menthol
inhibitedVGSCs in a state-, use-, and voltage-dependentmanner.
Moreover, menthol inhibited repetitive firing and the amplitudes
of action potentials, inhibited spontaneous synaptic transmission
and decreased excitability in cultured superficial dorsal horn
neurons. The examination of brain menthol concentrations
showed that, when applied systemically, menthol is rapidly
accumulated in the brain tissue (Pan et al., 2012), suggesting that
this compound induces analgesic effect on inflammatory pain
models via inhibition of VGSCs in the central nervous system. In
another study (Kawasaki et al., 2013), both (−) and (+)-menthol
concentration-dependently decreased the peak amplitudes of
compound action potentials (CAPs) with the IC50 values of 1.1
and 0.93 mM, respectively. (−)-menthone and (+)-menthone
also suppressed CAPs with extents similar to that of menthol
(Kawasaki et al., 2013).
A recent study in mouse cortical neurons (Pezzoli et al.,
2014) reported that menthol (250 µM) dampens the generation
of action potentials in a time- and voltage-dependent manner
in TRPM8 knock-out mice and in the presence of a TRPM8
blocker. The effects of menthol were also studied on seizures
induced by in vitro gabazine applications. Menthol decreased the
duration and the number of action potential bursts. In addition,
an increase in the concentration of gabazine was needed to elicit
seizures. The results suggest that menthol can modulate VGSCs
of cortical neurons in the brain through a TRP-independent
pathway (Pezzoli et al., 2014).
Voltage-Gated Calcium Channels
Voltage-gated Ca2+ channels (VGCCs) are required for key
functions in excitable cell. (Hofmann et al., 2014; Simms
and Zamponi, 2014). The opening of VGCCs by changes in
membrane depolarization causes rapid increases in cytoplasmic
Ca2+ concentration. Elevated Ca2+ levels can trigger key cellular
events such as contraction, exocytosis, gene transcription, and
excitability (Badou et al., 2013; Bannister and Beam, 2013; Reuter
et al., 2013).
Several earlier reports have demonstrated that menthol
modulates the functional properties of VGCCs. In LA-N-5
cells, brief application of menthol inhibited the depolarization-
induced Ca2+ influx though both dihydropyridine-sensitive and
-insensitive L-type Ca2+ channels with IC50 value of 0.25mM
(Sidell et al., 1990). Ca2+ increases induced by high K+ were
suppressed by menthol in Leech neurons (Dierkes et al., 1997),
chick retinal neurons and synaptosomes (Hawthorn et al.,
1988). It was shown that menthol suppresses high K+-elicited
and electrically stimulated contractile responses in atrial and
papillary muscles and in ileum. IC50 values in the ileum tissue
ranged from 8 to 28 µg/ml and in the cardiac preparations
from 10 to 69 µg/ml. Notably, menthol acts as a competitive
inhibitor on the specific binding of [3H]PN 200-110 and [3H]
nitrendipine, dihydropyridine class antagonists of L-type Ca2+
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channels in cardiac and smooth muscles and neuronal tissue
with potencies similar to those determined in earlier studies
(Hawthorn et al., 1988). In tracheal (Ito et al., 2008) and bronchial
(Wright et al., 1997) smooth muscle fibers, vas deference
(Filippov et al., 2009; Vladymyrova et al., 2011), and detrusor
muscle (Ramos-Filho et al., 2014), menthol decreased the KCl-
and ACh-induced muscle contractures by inhibiting of L-type
VGCCs. Recent study in tracheal smooth muscle preparation
reported that methacholine and electrical field stimulation
induced contractions were suppressed significantly by menthol
and suggested that VGCCs were affected by this compound
(Wang et al., 2016).
Consistent with earlier findings, menthol was demonstrated
to cause relaxation and suppress contraction in coronary and
mesenteric arteries, and rat aorta (Cheang et al., 2013), mainly
by decreasing the influx of Ca2+ via dihydropyridine-sensitive
L-type VGCCs. In addition, menthol (0.1–30 mM) inhibited the
contractility of the gastrointestinal smooth muscle and induced
spasmolytic effects in human colon circular muscle by inhibiting
the entrance of Ca2+ through L-type VGCCs (Amato et al.,
2014a). Peppermint oil has also been shown to reduce the
contractions evoked by high K+ and Ca2+ in guinea pig taenia
coli by inhibiting L-type VGCCs (Hills and Aaronson, 1991).
Several electrophysiological studies investigated the effects
of menthol on currents mediated by VGCCs. In a previous
investigation, the effects of menthol (0.1–0.5 mM) on the
inactivation of Ca2+ currents were examined in Helix neurons
(Swandulla et al., 1986). Although internal application was
ineffective, external application of menthol caused acceleration
of inactivation during Ca2+-dependent rapid phase. In following
experiments, the actions of menthol on Ca2+ current were
examined in cultured DRG neurons from embryos of rat and
chick (Swandulla et al., 1987). Bath application of menthol (0.1–
1mM) caused various types of effects on different kinds of Ca2+
currents in these neurons. Below membrane potential of −20
mV, menthol suppressed the amplitudes of low threshold (T-
type like) Ca2+ currents in a dose-dependent fashion; with no
alteration of activation kinetics. On the other hand, externally
applied menthol significantly accelerated the inactivation of the
L-type (high-threshold) Ca2+ currents (activated from a holding
potential of −80 mV to positive potentials above −20 mV). The
effects of menthol remained unaltered at holding potentials more
positive than −20 mV. Importantly, the effect of menthol was
observed only when it was applied from the outside. Together,
findings of this investigation showed that menthol inhibits Ca2+
influx through the low voltage-activated Ca2+ channel, and
enhances the inactivation of the L-type (high voltage-activated)
Ca2+ channel.
Succeeding these investigations in neurons, the effects of
menthol on L-type VGCCs of rabbit ventricular myocyte
was studied using whole-cell recording technique at near-
physiological temperature (∼35◦C) (Baylie et al., 2010). Menthol
inhibited peak amplitudes of Ca2+ currents in a concentration-
dependent manner with an IC50 value of 74.6 µM. The late
currents remaining at the end of depolarizing pulses were also
suppressed by menthol. Menthol inhibited these late currents
with greater efficacy (96% block at 1 mM) than peak (68% block
at 1 mM) Ca2+ currents (Baylie et al., 2010). Similarly, inhibition
of L-type VGCCs by menthol has also been shown in smooth
muscle cells (Melanaphy et al., 2016).
The effects of menthol are not limited to Ca2+ influx through
VGCCs. Menthol has significant effect on other components of
Ca2+ homeostasis as well. For example, it has been shown that
(Mahieu et al., 2007; Wondergem and Bartley, 2009; Neumann
and Copello, 2011; Melanaphy et al., 2016), menthol induces
Ca2+ release from intracellular stores. In addition, menthol has
been shown to induce activation of IP3 receptors (Melanaphy
et al., 2016), and RyR1 ryanodine receptors with an approximate
EC50 of 1 mM (Palade, 1987; Neumann and Copello, 2011).
Thus, it is likely that some of the menthol actions are due to
enhancement of Ca2+-induced inactivation of VGCCs and/or
activations of second messenger pathways as a result of alteration
in intracellular Ca2+ levels.
Voltage-Gated Potassium Channels
Voltage-gated K+ channels (VGKCs) are important membrane
proteins embedded into lipid bilayer membrane. Stimulation
of VGKCs by depolarizing membrane potentials leads to
opening of these channels and causes the hyperpolarization of
excitable cells. The VGKCs are broadly distributed throughout
the mammalian tissues and play vital roles in dampening
cellular excitability under several pathological and physiological
conditions (Maljevic and Lerche, 2013; Tian et al., 2014). Some of
the physiological functions of K+ channels include determining
the action potential duration, changing the interspike intervals
during repetitive firing of the heart and neurons, secreting K+
in epithelial tissue, and causing smooth muscle contractions
(Maljevic and Lerche, 2013; Tian et al., 2014). These channels are
composed of four subunits, gathered in the cell membranes as
tetrameric structures. Due to the large number of different genes
present, auxiliary β-subunits and metabolic regulation, there
is considerable functional diversity among different subtypes
(González et al., 2012; Latorre et al., 2013).
Data on the effect of menthol on K+ channels are rather
limited. In human glioblastoma cells, Ca2+-activated K+ currents
were demonstrated to be stimulated by menthol (Wondergem
and Bartley, 2009). Recently, using a dye sensitive to membrane
potential, menthol was reported to suppress Kv7.2/3 channel
subtypes that produce the M-current in neurons with IC50 value
of 289 µM (Vetter et al., 2013). However, further investigations
are needed to assess the importance of menthol as a modulator of
VGKCs in various cell types.
Transient Receptor Potential Channels
Transient Receptor Potential (TRP) superfamily of non-selective
cation channels are encoded by more than 30 distinct genes
in mammals and play important roles in sensory physiology,
which include contributions to thermo- and osmosensation,
vision, touching, olfaction, taste, and hearing (Nilius and Szallasi,
2014). TRP channels have tetrameric structures formed by six
transmembrane domain subunits and cation-selective pores,
which usually show high permeability to calcium (Latorre et al.,
2009). TRP channels in mammalian cells are composed of
seven families of related proteins: TRPM (melastatin), TRPA
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(ankyrin-like), TRPV (vanilloid), TRPC (classical or canonical),
TRPN (no mechanoreceptor potential C) TRPML (mucolipin),
and TRPPP (polycysteine) (Clapham and Squire, 2009; Gees
et al., 2012; Nilius and Szallasi, 2014). In addition to sensory
physiology, these channels play diverse functional roles ranging
from modification of growth cone morphology to intracellular
Ca2+ homeostasis (Freichel and Flockerzi, 2007; Julius, 2013;
Nilius and Appendino, 2013; Billeter et al., 2014). Importantly,
majority of TRP channels function as polymodal sensors. These
channels are activated by physical stimuli such as stretch, osmotic
pressure, membrane voltage, and temperature as well as chemical
stimuli, fatty acids and other membrane lipids (Bradshaw et al.,
2013). Besides direct activation by physical stimuli, unliganded
TRP channels can also be stimulated by G-protein coupled
receptors (Veldhuis et al., 2015) and receptor tyrosine kinases
(Nilius and Szallasi, 2014).
Menthol, in the concentrations ranging from 10 µM to 1
mM, has been reported to stimulate TRPM8 receptors (McKemy
et al., 2002; Peier et al., 2002). Intracellular Ca2+ levels have
been shown to be elevated by menthol in a concentration-
dependent manner in HEK293 and CHO cells overexpressing
TRPM8. Patch-clamp experiments in sensory neurons have
demonstrated that activation of TRPM8 receptors induces
outwardly rectifying, Ca2+ permeable cation currents that show
strong resemblances to the endogenous menthol- and cold-
activated currents (McKemy et al., 2002; Peier et al., 2002). An
examination of the voltage dependence of currents mediated by
TRPM8 receptors showed that cold and menthol employ the
similar mechanism to activate this channel. It appears that both
menthol and cold shift the voltage-dependent activation curve of
TRPM8 to more physiological potentials (Voets et al., 2004).
Structures of TRP channels are tetrameric and composed of
four subunits containing six transmembrane segments (TM1–
TM6). Mutation of residues sensitive to potential changes in
the TM4 and the TM4-TM5 linker effects menthol- and cold-
sensitivity of TRPM8 receptors (Voets et al., 2007). Random
mutagenesis screening studies indicated that tyrosine 745,
located in the middle of putative transmembrane segment 2,
is as a crucial amino acid residue for the menthol sensitivity
of mouse TRPM8 receptor (Bandell et al., 2006). Receptor-
channel complex that contains TRPM8-Y745H mutation was
found to be not sensitive to menthol, but retained the voltage
and cold sensitivity of the wild-type channel. In another study,
it was proposed that single TRPM8 channel can independently
bind up to four menthol molecules, and that bound menthol
molecules cause a similar energetic stabilization of the open
channel (Janssens and Voets, 2011). Menthol sensitivity of
TRPM8 receptors has also been shown to be influenced by post-
translational modifications such as glycosylation (Pertusa et al.,
2012). It seems that reduction of TRPM8 glycosylation causes
a significant decrease in the menthol responsiveness of TRPM8
receptor (Pertusa et al., 2012). Another feature that appears
to influence sensitivity of TRPM8 receptors to menthol is the
bilayer lipid structure of the plasma membranes. Interestingly,
disturbance by methyl-β-cyclodextrin of lipid rafts has been
demonstrated to increase stimulation of TRPM8 receptors by
menthol (Morenilla-Palao et al., 2009).
Notably, the interaction between menthol and TRPM8
receptor is not limited to excitable cells. Various non-excitable
cancer cells expressing TRPM8 receptors has also been shown to
be affected by menthol. For example, menthol has been shown to
inhibit growth of humanmelanoma cells via activation of TRPM8
receptors (Slominski, 2008; Yamamura et al., 2008). Similarly,
menthol has been reported to induce cell death via the TRPM8
receptor in the human bladder cancer cell line T24 (Li et al.,
2009) indicating that menthol modulation of TRPM8 receptors
may have some clinical implications as well.
Besides menthol, in the concentrations ranging from 100
µM to 10mM, many monoterpenes with structures similar to
menthol, including carvone, isopulegol, and euganol (Bandell
et al., 2004), linalool, geraniol, eucalyptol, citronellal (Behrendt
et al., 2004), and menthone (McKemy et al., 2002) also stimulate
TRPM8 receptors (for a review Oz et al., 2015). However, actions
of these compounds, compared tomenthol, are less described and
it is not clear if they utilize the same binding site as menthol on
the TRPM8 receptor.
Among naturally occurring TRP ligands some extent of
promiscuity exists. For example, the monoterpene menthol,
generally considered a TRPM8-specific agonist, was reported
to activate TRPV3 (Macpherson et al., 2006; Vogt-Eisele et al.,
2007) and TRPA1 (Karashima et al., 2007) receptors. It appears
that menthol in the range of submicromolar to low-micromolar
concentrations, causes activation of TRPA1 channel, whereas at
higher concentrations menthol leads to a reversible blockade
of the channel (Karashima et al., 2007). Menthol has also
been shown to induce membrane depolarizations by activating
TRPA1 channels in interstitial cells of Cajal (Kim et al.,
2016). While activation of TRPM8 by menthol occurs with an
EC50 of approximately in the range of 4–80 µM (McKemy
et al., 2002; Peier et al., 2002; Behrendt et al., 2004), higher
menthol concentrations are required for modulation of other
thermosensitive TRP channels.
Earlier studies have also shown TRP channel-independent
actions of menthol. In various cell types, including skeletal
muscle sarcoplasmic reticulum (Palade, 1987; Neumann and
Copello, 2011; EC50 = 0.9–1 mM), tracheal epithelial cells
(Takeuchi et al., 1994; 100 µM–1 mM) human leukemia cells
(Lu et al., 2006; 25 to 100 µM), gliablastoma cells (Wondergem
and Bartley, 2009; 100µM), commonly used cell lines (HEK-293,
LNCaP, CHO, and COS, Mahieu et al., 2007; 100 µM–1mM)
and dorsal horn neurons (Tsuzuki et al., 2004, 100 µM–1mM),
menthol has been shown to increase intracellular Ca2+ levels
independently of TRP-channel activation.
Menthol also directly inhibits the activity of several enzymes
(Kim et al., 2008, 2009). In HEK-293 and HeLa cells, menthol,
in the concentrations of 0.3–1 mM, causes significant inhibition
of P2Y purinoceptor-mediated or histamine receptor-mediated
cytosolic Ca2+ mobilization (Kim et al., 2008). The results of
further biochemical experiments in this study indicated that
menthol inhibits the activity of PLC directly. Furthermore, the
authors have shown that ADP-stimulated aggregation of human
erythrocytes was blocked by menthol, suggesting that menthol
can be a clinically useful agent to prevent platelet aggregation.
Similarly, in PC-3 cells, phosphorylation of c-jun N-terminal
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kinase (JNK) was significantly potentiated bymenthol (Kim et al.,
2009).
In human airway Calu-3 epithelial cells that do not express
TRPM8 channels, menthol (0.1–1 mM) heterologously regulates
anion transport through cAMP-independent mechanisms by
potentiating the cystic fibrosis transmembrane conductance
regulator (CFTR)- mediated Cl− transport (EC50 = 190µM) and
by down regulating Na+-K+-2C1− transporter activity (Morise
et al., 2010). It is concluded that the actions of menthol on
actin cytoskeleton which interacts with these anion transporters
mediates the observed effects of menthol on epithelial Cl-
transport and suggested that menthol may have beneficial
actions in treatment of cystic fibrosis (Morise et al., 2010).
Similarly, menthol has been shown to interfere with tubulin
depolymerization and promote apoptosis (Faridi et al., 2011).
Overall, these studies indicate that menthol causes several effects
on intracellular Ca2+ levels and other cellular events independent
of TRP-channels.
GABA and Glycine Receptors
Receptors for inhibitory neurotransmitters γ-amino butyric acid
(GABA) and glycine (Gly) belong to pentameric ligand-gated
ion channel family. These receptors respond to GABA and
Gly by opening a chloride-selective central pore. In the central
nervous system, GABA is the major inhibitory neurotransmitter.
It is synthesized in GABAergic neurons and in response to
action potential, it is released from presynaptic buttons into the
synaptic cleft. Subsequent to its release, GABA acts primarily
at two different types of receptors: first the ionotropic GABAA
receptors and secondly, the metabotropic, G-protein coupled
GABAB receptors. In case of GABAA receptors, binding of
GABA to its receptor causes a conformational change in its
structure and leads to the opening of the channel. Activation of
GABAA receptors causes hyperpolarization and eventually the
suppression of neuronal activity (Fritschy et al., 2012; Sigel and
Steinmann, 2012). On the other hand, the receptors for Gly are
located primarily in the spinal cord and brain stem. Following
its release from nerve endings, Gly binds to post-synaptic Gly
receptor and opens a chloride channel intrinsic to the receptor
(Yevenes and Zeilhofer, 2011; Dutertre et al., 2012).
In recent years, the actions of menthol and structurally
related monoterpene analogs on GABAA-receptors have
attracted considerable attention. Notably, in majority of earlier
investigations menthol was found to upregulate the function
of GABAA-receptors. In a previous investigation, actions of
menthol and its structural analogs (monoterpenoid alcohols
and ketones) were examined on recombinant human GABAA
(α1β2γ2s) and glycine (α1 homomers) receptors expressed
in Xenopus oocytes (Hall et al., 2004). Monoterpences, in the
concentration range of 10–300 µM, caused a significant increase
of GABA-induced currents in the following order: (+)-menthol
> (−)-menthol > borneol > menthone = camphor = carvone.
In this study menthol was found to be activated stereoselectively
(Hall et al., 2004). Importantly, menthol up to concentration
of 1 mM did not induce any ion current indicating that this
compound does not have direct agonist activity on GABAA
receptor. Given its marked effects (e.g., at 100 µM, GABA and
glycine EC20 responses increased by 496 and 135%, respectively)
potentiating effects of menthol was further investigated.
Menthol, 100 µM, reduced EC50 values for Gly and GABA from
98 to 75 µM, and from 82 to 25 µM respectively, without a
significant effect on maximal responses (Hall et al., 2004).
In further studies on human α1β2γ2s GABAA receptors
expressed in Xenopus laevis oocytes (Watt et al., 2008), it was
reported that when these compounds were co-applied with
sub-maximal (EC20) GABA concentrations, the amplitudes of
current responses were increased in concentration-dependent
manner in the following order: (+)-menthol > isopulegol
> isomenthol > α-terpineol >> cyclohexanol. Importantly,
flumazenil (a benzodiazepine antagonist) did not reverse
menthol enhancement of GABA-induced currents while GABA
responses activated by propofol (50 µM) were significantly
suppressed by menthol (50 µM). GABAA receptors containing
β2 subunits with either a point mutation of a tyrosine to a
tryptophan at the 444 position (TM-4) or a methionine residue
to a tryptophan at the 286 position (in transmembrane domain
3, TM-3) are found to be insensitive to propofol modulation.
Potentiation of GABA EC20 currents by menthol were equally
eliminated in GABAA α1β2(M286W)γ2s and α1β2(Y444W)γ2s
receptors while potentiation by barbiturates, benzodiazepines,
and steroids remained unaltered (Watt et al., 2008). The findings
of this study showed that menthol acts on GABAA receptors via
a site related to propofol modulation but distinct from action
sites for barbiturates, benzodiazepines, and steroids. Finally,
application of menthol, in an in vivo tadpole assay, resulted
in a loss of righting reflex with an EC50 of 23 µM (∼10-fold
less potent anesthesia than propofol). Thus, it is possible that
menthol shares general anesthetic action with propofol (Watt
et al., 2008) possibly by acting at similar binding sites on the
GABAA receptor.
In radioligand binding studies, specific binding of [3H]-
flunitrazepam to GABAA receptors in primary cultures of mouse
cortical neurons was not altered by up to 500 µM concentrations
of menthol (García et al., 2006). In another investigation, it
was reported that only (+)-menthol, among the five menthol
stereoisomers studied, was found to be active in potentiating
the binding of [3H]-flunitrazepam, an allosteric ligand for
GABAA receptor (Corvalán et al., 2009) while (+) and (−)-
neomenthol were found to be inactive. In another radioligand
binding study, monoterpenes such as carvacrol, citronellic acid,
1,8-Cineole, thymol, and pulegone significantly increased the
specific binding of [3H]-tbutylbicycloorthobenzoate (TBOB), a
non-competitive inhibitor of picrotoxin. On the other hand,
menthol and other monoterpenoids such as vanillin, camphor,
and safrole, significantly suppressed the binding of [3H]-TBOB in
housefly head membrane preparations (Tong and Coats, 2012).
In another investigation, it was shown that the excitability
of cultured rat hippocampal neurons were inhibited menthol
(Zhang et al., 2008). In addition, menthol significantly inhibited
the epileptic activity induced by pentylenetetrazole injection and
electrical kindling in in vivo models (Zhang et al., 2008). It was
reported that menthol not only increased the currents activated
by low concentrations of GABA but also directly induced currents
mediated by GABAA receptors in cultured hippocampal neurons.
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In addition, menthol significantly increased tonic GABAergic
inhibition in the CA1 region of rat hippocampal slices. But phasic
GABAergic inhibition remained unaffected. The structure-effect
relationship of menthol suggested that hydroxyl group plays an
important role in the enhancement of tonic GABAA receptors by
menthol (Zhang et al., 2008). Another study examined the actions
of menthol on respiratory rhythm generation in the brainstem-
spinal cord preparations from newborn rats (Tani et al., 2010).
It was reported that menthol, by directly activating tonic GABA
receptors, caused a significant inhibition of burst generation in
pre-inspiratory neurons. In a recent study (Lau et al., 2014),
the effects of menthol on GABAA receptors were examined in
periaqueductal gray (PAG) neurons of midbrain slices It was
found that menthol (150–750 µM) induced prolongation of
spontaneous GABAA receptor-mediated inhibitory post-synaptic
currents in a concentration-dependent manner, but non-NMDA
receptor-mediated excitatory post-synaptic currents remained
unaltered. Effects of menthol were not changed by antagonists
of TRPM8 and TRPA1 receptors, flumezanil, a benzodiazepine
antagonist, and tetrodotoxin, sodium channel blocker. A tonic
current, which was sensitive to the bicuculline and picrotoxin
(both are GABAA receptor antagonists) was also enhanced
by menthol. These results indicated that both synaptic and
extrasynaptic populations of GABAA receptors are positively
modulated by menthol in native PAG neurons.
The action of menthol on the Gly receptors are relatively
less studied in comparison to GABAA receptors. In an earlier
investigation (Hall et al., 2004), actions of menthol were studied
on homomeric α1 glycine receptors expressed in Xenopus
oocytes. It was reported that the function of Gly receptors was
significantly enhanced by both (+) and (−) enantiomers of
menthol and borneol.
Serotonin Type-3 Receptors
Serotonin type-3 (5-HT3) receptors belong to Cys-loop family of
ligand-gated ion channel family and therefore differ structurally
and functionally from other G-protein coupled serotonin
receptors. Human 5-HT3 receptors are proposed to play
important roles in neurodevelopment, nociception, psychiatric
disorders such as depression, and motility of gastrointestinal
system (Lummis, 2012; Engel et al., 2013). The actions of
menthol on the functional properties of 5-HT3 receptors were
studied in recent investigations (Heimes et al., 2011; Ashoor
et al., 2013b; Walstab et al., 2014; Ziemba et al., 2015).
Actions of menthol on 5-HT3 receptors were studied by
Heimes et al. (2011) utilizing three different in vitro models:
isotonic contractions of the isolated rat ileum and equilibrium
competition binding studies using [3H]GR65630, a 5-HT3
receptor antagonist, and [14C] guanidinium influx into N1E-
115 cells which express 5-HT3 receptors. Application of menthol
suppressed [14C]guanidinium influx through 5-HT3 receptors as
well as 5-HT induced contractions of the ileum. However, specific
binding of [3H]GR65630 to 5-HT3 receptor was not altered by
menthol. In this investigation, it was suggested that antiemetic
actions of menthol occur at least partly by acting as a negative
allosteric modulator of the 5-HT3 receptors; in other words, by
binding to an allosteric modulatory site which is distinct from
the binding site of serotonin. In another recent investigation,
Ashoor et al. (2013b) studied the actions of menthol on the
functional properties of human 5-HT3A receptors expressed in
X. laevis oocytes. Menthol reversibly suppressed 5-HT-activated
inward currents in a concentration-dependent manner with an
IC50 value of 163 µM. The time course of the inhibitory effect of
menthol was slow and reached a steady-state level within 10–15
min. However, the effect did not involve G-proteins, since GTPγS
activity remained unchanged. In addition, pretreatment with
pertussis toxin, which inhibits Gi and Go proteins, did not alter
the extent of menthol inhibition. Racemic, (−), (+) menthols
inhibited 5-HT3 currents to the same extent suggesting that the
effects of menthol on 5-HT3 receptors are not stereoselective.
Increasing concentrations of 5-HT did not reverse the inhibition
induced by menthol. Moreover, menthol did not affect specific
binding of the [3H]GR65630, indicating that this compound acts
as a non-competitive antagonist of the 5-HT3 receptor. Finally,
in acutely dissociated nodose ganglion neurons, 5-HT3 receptor-
mediated currents were inhibited by menthol. The results of this
study indicated that in both heterologous expression systems and
in neurons, menthol acts as a negative allosteric modulator of
5-HT3 receptors. In another recent study actions of menthol
was investigated in HEK293 cells expressing human recombinant
homomeric 5-HT3A- and heteromeric 5-HT3AB receptors using a
luminescence-based Ca2+ assay, membrane potential assay, and
radioligand binding assay (Walstab et al., 2014). The results of
this study indicated that (−) isomer of menthol inhibited 5-HT3
receptors with an IC50 of 20 µM in a non-competitive manner.
Importantly, the potency of (+)-menthol was significantly less
than that of the (−) stereoisomer. In addition, (+)-menthol,
compared to (−) menthol, was significantly less potent on
5-HT3A vs 5-HT3AB receptors. Overall, (−)-menthol was 11-
fold more potent toward the homomeric 5-HT3A receptor.
Above-mentioned studies demonstrate that menthol is a negative
allosteric modulator of 5-HT3 receptors. Similar to menthol,
thujone, another monoterpene chemically related to menthol,
has also been demonstrated to suppress the function of 5-HT3
receptors (Deiml et al., 2004).
Nicotinic Acetylcholine Receptors
The nicotinic acetylcholine receptors (nAChRs) are cation-
permeable ion channel-receptor complex activated by the
neurotransmitter acetylcholine. The nAChRs is a member of
Cys-loop receptor family, which also includes the GABAA,
GABAC, Gly, and serotonin 5-HT3, receptors. The nAChRs
also play important roles in several physiological functions
and pathological conditions, including the modulation of
neurotransmitter release, the secretion of hormones, and
regulation of neuronal excitability (Dani and Bertrand, 2007;
Dineley et al., 2015). The nAChRs are expressed throughout
the neurons of central and peripheral nervous systems, as well
as cells of the other peripheral tissues (Dani and Bertrand,
2007; Albuquerque et al., 2009). Currently, nine different nAChR
subunits have shown to be expressed (α2-7 and β2-4) in
the mammalian brain. The subunits combinations, as either
homomeric or heteromeric complexes, can occur resulting in
functionally diverse pentameric receptors (Albuquerque et al.,
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2009; Dineley et al., 2015). The main receptor subtypes expressed
in the brain are α7 containing subunits and those composed of
both α and β subunits, including the α4β2∗ and α3β4∗ subtypes;
the ∗ designates that these receptors can contain other α and β
subunits as well. In searching for new selective molecules that
modulate the functional properties of nACh receptors, naturally
produced chemicals have shown to be a good source at least for
generations of structural models (Daly, 2005; Romanelli et al.,
2007).
In tobacco industry, menthol is commonly employed to
mask the unpleasant tobacco test, increase the ease of smoking
and offer a cooling sensation that appeal to many smokers
(Ahijevych and Garrett, 2004). Moreover, it has been reported
that menthol is present in 90 percent of tobacco products in
varying concentrations (Foulds et al., 2010). Menthol, as an
additive to tobacco products, has come under scrutiny following
several FDA reports (Benowitz and Samet, 2011), indicating that
menthol can enhance smoking behavior and stimulate adverse
effect of smoking on health (Kabbani, 2013; Wickham, 2015).
The results of epidemiological studies suggest that smoking of
mentholated cigarettes is more widespread in ethnic and racial
minority populations (Ahijevych and Garrett, 2010; Foulds et al.,
2010). It is also important to note that an association between
a difficulty in quitting smoking and smoking mentholated
cigarettes is also greater in ethnic and racial minority populations
as well as young smokers (Foulds et al., 2010). Therefore, it is
essential to investigate the cellular and molecular mechanisms of
interaction between nAChRs and menthol.
Functional interaction between nicotinic receptors and
menthol has been reported earlier both in vitro and in vivo
investigations (Dessirier et al., 2001; Ruskin et al., 2008; Willis
et al., 2011; Hans et al., 2012; Ashoor et al., 2013a; Amato
et al., 2014b). In an earlier study, it was found that menthol
significantly reduces sensory perception and irritation caused by
nicotine (Dessirier et al., 2001) and by inhalation of cigarette
smoke (Willis et al., 2011). In addition to these findings,
nicotine-induced decreases in body temperature, as a result
of cutaneous vasodilation, are reduced considerably following
the administration of both acute and chronic menthol (Ruskin
et al., 2008). In a recent investigation, the extent of gastric
relaxation induced by menthol was considerably decreased in
the presence of hexamethonium, a nAChR blocker (Amato
et al., 2014b). Menthol, at concentrations that did not alter
gastric tone, decreased the contraction caused by nAChR
agonist, dimethylphenylpiperazinium. The co-application of
hexamethonium and phentholamine, α-adrenergic receptor
antagonist or hexamethonium and atropine, muscarinic receptor
antagonist, did not cause any additive decrease of the menthol-
induced relaxation. In this study, authors concluded that the
interaction between nAChR and menthol is likely to be an
important stage for menthol-induced relaxation of gastric muscle
(Amato et al., 2014b).
Electrophysiological studies investigating the effects of
menthol on different nAChR subtypes have also been conducted
(Hans et al., 2012; Ashoor et al., 2013a). It was reported
that, in trigeminal neurons, nicotine-induced whole-cell currents
through nACh receptors was reversibly inhibited with an IC50
of 111 µM. Single channel experiments on human α4β2 nAChR
expressed in HEKtsA210 cells indicated that menthol induced
a decrease of channel open time, increase in single channel
amplitude, and increase of channel closed time leading to overall
reduction in single channel currents. Moreover, menthol did not
alter the potency (nicotine’s EC50 value) on recombinant human
α4β2 nAChRs but induced a substantial decrease in the efficacy
of nicotine. All together, these results demonstrated that menthol
is a negative allosteric modulator of α4β2 nAChRs (Hans et al.,
2012). Clinical studies employing positron emission tomography
scanning with the α4β2 radioligand indicated that, in line with
the results of in vitro studies, menthol smokers have 9–28%
higher α4β2 nAChR densities than non-menthol smokers across
regions (Brody et al., 2013).
In a recent study, the effect of long-term menthol application
was investigated on midbrain neurons containing nAChRs
(Henderson et al., 2016). Menthol alone increased the number of
α4 and α6 nAChR subunits in midbrain dopaminergic neurons
from mice expressing fluorescent nAChR subunits. However,
this upregulation did not occur in midbrain GABAergic
neurons suggesting that chronic menthol application produced
a cell-type-selective upregulation of α4∗ nAChRs. These
findings complemented that of chronic nicotine alone, which
upregulates α4 subunit-containing (α4∗) nAChRs in GABAergic
but not dopaminergic neurons. Further studies in cultured
midbrain neurons and mouse brain slices indicated that menthol
decreased dopaminergic neuron firing frequency and altered
dopaminergic neuron excitability following nAChR activation.
Furthermore, exposure to menthol before nicotine stopped
nicotine reward-related behavior in mice. In neuroblastoma
cells transfected with fluorescent nAChR subunits, exposure
to menthol (500 nM) alone also increased the number of
nAChRs and favored the formation of (α4)3(β2)2 nAChRs.
This effect contrasted with the action of nicotine, which favors
(α4)2(β2)3 nAChRs (Henderson et al., 2016). Menthol alone
also increases the number of α6β2 receptors that exclude the
β3 subunit. Thus, it appears that lower-sensitivity α4∗ and
α6 subunit-containing nAChRs were stabilized by menthol.
The suppression of nicotine reward-related behavior may be
mediated through menthol’s ability to stabilize lower-sensitivity
nAChRs and alter dopaminergic neuron excitability. Overall
these studies indicated that menthol increases the number of
nAChRs in the mouse brain at a dose that matches nicotine in
its ability to increase nAChR number. Menthol also changes
the function of midbrain dopamine neurons, and prevents
behaviors related to nicotine reward. These findings suggest
that menthol is more than an “inert” additive to tobacco
and it is able to alter the functional properties of midbrain
dopamine neurons in the mesolimbic reward pathway. In
fact, another recent study indicate that menthol enhances
nicotine-induced changes in nAChRs expressed on midbrain
dopaminergic neurons (Henderson et al., 2017). Menthol plus
nicotine upregulates nAChR number and function on midbrain
dopaminergic neurons more than nicotine alone. Menthol
also enhances nicotine-induced changes in dopaminergic
neuron excitability. Furthermore, in a conditioned place
preference assay, menthol plus nicotine produces greater
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reward-related behavior than nicotine alone (Henderson et al.,
2017).
In addition to α4β2 containing receptors, function of α7
nAChRs was also reported to be altered by menthol. Utilizing
a two-electrode voltage-clamp technique, it was demonstrated
that menthol reversibly inhibited human α7-nACh receptors
expressed in Xenopus oocytes (Ashoor et al., 2013a). Inhibitory
effect of menthol did not involve the activation of endogenously
expressed Ca2+-dependent Cl− channels in oocytes and the
effect was not dependent on changes in the membrane potential.
Moreover, increasing the concentrations of ACh did not alter
the inhibition by menthol. In addition, the specific binding of α-
bungarotoxin was not changed by menthol. Furthermore, studies
of α7-nACh receptors endogenously expressed in neuronal cells
indicated that menthol suppresses Ca2+ transients mediated by
the activation of α7-nACh receptors in the cell body and neurite.
Over all, these findings indicate that menthol non-competitively
inhibits the function of α7-nACh receptors (Ashoor et al., 2013a).
In addition to centrally located α7 and α4β2 nAChRs, the
effects of menthol have also been reported on α3β4, the major
nicotinic subtype expressed in sensory nerves (Ton et al.,
2015). In this study, menthol markedly suppressed the activity
of nAChR as assessed by 86Rb+ eﬄux, Ca2+ imaging, and
voltage-clamp experiments. Menthol inhibited the function of
nAChRs in a voltage-independent manner. In addition, menthol
decreased the mean open time of single channels without
altering their conductance, disagreeing with a simple channel-
blocking action. Furthermore, the recovery of nAChRs from
desensitization menthol was significantly slowed or prevented
by menthol, suggesting that menthol probably stabilizes a
desensitized state of nAChRs. It was also demonstrated that
menthol at concentrations up to 1 mM did not interact with
the orthosteric nAChR binding site labeled by [3H] epibatidine,
indicating that menthol causes desensitization of α3β4 nAChRs
by an allosteric mechanism (Ton et al., 2015).
In conclusion, in both neural and non-neural nACh receptors,
menthol presented a significant activity on the function of nACh
receptor that requires further investigations. Drug development
efforts have recently focused on direct manipulation of α7
and α4β2 nACh receptors. Menthol and related monoterpenes
could be helpful in developing compounds that influence
different nAChR subtypes or provide high selectivity for these
subtypes.
RELEVANT MENTHOL CONCENTRATIONS
In the literature, there are some pharmacokinetic studies available
for menthol. In an earlier study, the no-observed-adverse-effect-
level after oral intake was found to be 667 mg/kg/day (National
Toxicology Program, 1979). The lethal menthol concentration in
orally fed mice was reported to be in the range of 2,900–6,000
mg/kg body weight, indicating that menthol, at the doses used
in most in vitro studies (10 µM to 10 mM) is well-tolerated.
In another study, the plasma menthol concentration rose to
20µM within 1 h in rats that have been administered 400 mg
of menthol/kg body weight I.P. (Spichiger et al., 2004). In an
earlier study in rodents, it was reported that the average nasal
tissue concentration of inhaled menthol applications (at 0.65
µM in vapor or 16 ppm) was about 150 µM (Willis et al.,
2011). In clinical studies, topical menthol application (30%; 1.9
M) has been employed consistently, without initiating any skin
irritation or other side effects (Hatem et al., 2006). These results
indicate that the effects of menthol used in the concentration
range of 10 µM to 10 mM in most in vitro studies are likely to
be pharmacologically relevant. In addition, the concentrations of
menthol utilized in in vitro studies are below or within the range
of FDA regulated concentrations utilized in creams (2% v/v; 128
mM) and over-the-counter pain rubs (4% v/v; 256 mM) (OECD,
2003).
MECHANISMS OF MENTHOL ACTIONS
Menthol, as mentioned earlier, is a highly hydrophobic
compound with Log p value of 3.4 (Turina et al., 2006;
Zunino et al., 2011). In line with these findings, menthol and
other structurally related monoterpenes partition into biological
membranes and cause significant alterations in numerous
physico-chemical characteristics of lipid bilayers (Sánchez et al.,
2004; Turina et al., 2006; Zunino et al., 2011). A central question
has been if the effects of these hydrophobic compounds are
mediated by their direct interaction with integral membrane
proteins (for example ion channels and transporters) and/or
by altering the physico-chemical characteristics of the lipid
membranes and indirectly affecting channel function (Lee, 2011).
This dichotomy demonstrates a main challenge in understanding
the mechanisms of not only menthol actions but also other
hydrophobic compounds such as general anesthetics (Howard
et al., 2014) alcohols (for a review Howard et al., 2014; Trudell
et al., 2014), terpenes (Oz et al., 2015), steroids (Hill et al.,
2015), and endocannabinoids (Oz, 2006). It appears that these
hydrophobic molecules bind to sites that are distinct from the
sites for binding probes (radioligands or toxins) and cause
significant alterations on functions of these channels (Anishkin
et al., 2014; Poveda et al., 2014). It is likely that the lipophilic
molecules such asmenthol partition into lipid bilayermembranes
and alter the gating properties of both voltage- and ligand-
gated ion channels. In most in vitro studies, menthol and other
hydrophobic monoterpenes have been shown to act on ion
channels at a concentration range of 10 µM to 10 mM. In fact,
this is not a unique pharmacological property of monoterpenes.
Several other hydrophobic molecules, such as alcohols and
general anesthetics also act at similarly high concentrations (high
µM to low mM).
In earlier studies, it has been shown that all voltage-
gated ion channels (VGICs) comprises a common domain
of six helical transmembrane segments (S1–S6). Among these
segments, S4 has been shown to have a symmetrical arrangement
of charged amino acids, with each third amino acid being
lysine or arginine. Hence, S4 has been thought as the key
contender for the voltage-sensing segment of VGICs. Previous
crystallographic examinations of KcsA K+ channels have shown
that the gating domain of the channel is located at the
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lipid-protein interface (Valiyaveetil et al., 2002; Ruta and
MacKinnon, 2004). It is possible that gating domains of
other VGICs also have similar orientations (Lee et al., 2005;
Moreau et al., 2014; Poveda et al., 2014). In this situation,
hydrophobic allosteric modulators such as menthol and other
monoterpenes can operate as gating modifiers by altering the
energy constraints for the movement of lipid-embedded gating
domains of VGICs. As a result, changes in energy requirements
of gating related conformational alterations of membrane
proteins can be due to menthol-induced modifications in
physicochemical characteristics of membranes. In a number of
previous investigations, physiochemical characteristics of lipid
bilayer membranes such as membrane fluidity and membrane
thickness have been shown to be modified by menthol and other
related monoterpenes (Sánchez et al., 2004; Turina et al., 2006;
Reiner et al., 2009; Zunino et al., 2011).
It is known that, similar to VGIC, the energetic requirements
for gating-related conformational alterations of ligand-gated
ion channels (LGICs) also can be changed by actions of
menthol on lipid membranes. In previous investigations, it
was demonstrated that even slight changes in adjacent lipid
structure can cause important alterations in the function of
LGICs by changing the energetics of conformational transitions
in the protein structure (Fantini and Barrantes, 2009; Barrantes
et al., 2010). Besides their interaction with membranes, menthol
and other monoterpenes can bind directly to residues of the
transmembrane domains and alter the functional properties
of LGICs. For instance, a recent investigation has identified
transmembrane residues that eliminate the agonist action of
thymol and carvacrol on human 5-HT3 receptors, or confer
this property on mouse 5-HT3 receptors that are previously
insensitive to these compounds (Lansdell et al., 2015). Moreover,
at least in some investigations, stereoselectivity for the effects
of monoterpenes was demonstrated (Hall et al., 2004; Watt
et al., 2008; Corvalán et al., 2009; Gonçalves et al., 2010;
Heimes et al., 2011; Kawasaki et al., 2013; Walstab et al., 2014).
Furthermore, specific amino acid residues mediating the actions
of monoterpenes were identified on 5-HT3 (Lansdell et al., 2015)
and GABAA receptors (Watt et al., 2008). Thus, it is possible
that both direct binding of hydrophobic compounds to ion
channel residues and changing the physicochemical properties
of biological membranes can contribute to overall actions of
menthol and other monoterpenes on the functional properties of
ion channels.
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